ınvestigation of the Relationship Between Scapular Position and Upper Extremity Performance in Adolescents With Idiopathic Scoliosis

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Adolescent Idiopathic Scoliosis s a three-dimensional spinal deformity that may alter shoulder girdle alignment, scapular orientation, and upper extremity biomechanics. Changes in scapular position can influence arm movement, muscle activation, and overall functional performance. Understanding these relationships is clinically important for developing effective exercise and rehabilitation strategies. The aim of this study is to examine the association between scapular position and upper extremity performance in adolescents diagnosed with Adolescent Idiopathic Scoliosis. Scapular dyskinesis, scapular lateral displacement, and upper limb functional performance will be evaluated and correlated with Cobb angle severity. Findings may help clinicians better understand functional impairments linked to scoliosis and support more targeted rehabilitation programs.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 10
Maximum Age: 19
Healthy Volunteers: f
View:

• Diagnosis of Adolescent Idiopathic Scoliosis

• Age 10-19 years

• Cobb angle between 10° and 45°

• No prior scoliosis-specific conservative treatment

• Ability to participate in physical assessments

• Voluntary willingness to participate

Locations
Other Locations
Turkey
Istinye University
RECRUITING
Istanbul
Contact Information
Primary
Kubra Kardeş, Asst. Prof.
kubra.koce@istinye.edu.tr
05387115631
Time Frame
Start Date: 2025-11-20
Estimated Completion Date: 2026-02-28
Participants
Target number of participants: 20
Treatments
Adolescent Idiopathic Scoliosis Group
Participants with Adolescent Idiopathic Scoliosis underwent assessments of scapular dyskinesis, scapular lateral displacement, and upper extremity performance using standardized functional tests.
Related Therapeutic Areas
Sponsors
Leads: Istinye University

This content was sourced from clinicaltrials.gov